QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, April 4, 2007, 27(14):3639-3649; doi:10.1523/JNEUROSCI.4396-06.2007

This Article Full Text Full Text (PDF) Supplemental Data Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (37) Citing Articles via Google Scholar Google Scholar Articles by Zhao, J. Articles by Vassar, R. Search for Related Content PubMed PubMed Citation Articles by Zhao, J. Articles by Vassar, R.

 Previous Article  |  Next Article 

Neurobiology of Disease
ß-Site Amyloid Precursor Protein Cleaving Enzyme 1 Levels Become Elevated in Neurons around Amyloid Plaques: Implications for Alzheimer's Disease Pathogenesis

Jie Zhao,¹ Yifan Fu,¹ Marina Yasvoina,¹ Peizhen Shao,¹ Brian Hitt,¹ Tracy O'Connor,¹ Sreemathi Logan,¹ Erika Maus,¹ Martin Citron,² Robert Berry,¹ Lester Binder,¹ and Robert Vassar¹

¹Department of Cell & Molecular Biology, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, and ²Amgen, Inc., Thousand Oaks, California 91320

Correspondence should be addressed to Dr. Robert Vassar, Department of Cell & Molecular Biology, Northwestern University Feinberg School of Medicine, 303 East Chicago Avenue, Chicago, IL 60611. Email: r-vassar{at}northwestern.edu

ß-Site amyloid precursor protein cleaving enzyme 1 (BACE1) (ß-secretase) initiates generation of ß-amyloid (Aß), which plays an early role in Alzheimer's disease (AD). BACE1 levels are increased in postmortem AD brain, suggesting BACE1 elevation promotes Aß production and AD. Alternatively, the BACE1 increase may be an epiphenomenon of late-stage AD. To distinguish between these possibilities, we analyzed BACE1 elevation using a highly specific BACE1 antibody, BACE-Cat1, made in BACE1–/– mice, which mount a robust anti-BACE1 immune response. Previous BACE1 immunohistochemical studies lack consistent results because typical BACE1 antibodies produce nonspecific background, but BACE-Cat1 immunolabels BACE1 only. BACE1 elevation was recapitulated in two amyloid precursor protein (APP) transgenic mouse lines. 5XFAD mice form amyloid plaques at young ages and exhibit neuron loss. In contrast, Tg2576 form plaques at a more advanced age and do not show cell death. These two mouse lines allow differentiation between early Aß-induced events and late phenomena related to neuron death. BACE1 levels became elevated in parallel with amyloid burden in each APP transgenic, starting early in 5XFAD and late in Tg2576. The increase in BACE1 protein occurred without any change in BACE1 mRNA level, indicating a posttranscriptional mechanism. In APP transgenic and AD brains, high BACE1 levels were observed in an annulus around Aß42-positive plaque cores and colocalized with neuronal proteins. These results demonstrate that amyloid plaques induce BACE1 in surrounding neurons at early stages of pathology before neuron death occurs. We conclude that BACE1 elevation is most likely triggered by the amyloid pathway and may drive a positive-feedback loop in AD.

Key words: APP transgenic; BACE-Cat1; ß-secretase; neurodegeneration; Tg2576; 5XFAD

---

Received Oct. 9, 2006; revised Feb. 15, 2007; accepted Feb. 18, 2007.

Correspondence should be addressed to Dr. Robert Vassar, Department of Cell & Molecular Biology, Northwestern University Feinberg School of Medicine, 303 East Chicago Avenue, Chicago, IL 60611. Email: r-vassar{at}northwestern.edu

This article has been cited by other articles:

				Q. Shi, M. Prior, W. He, X. Tang, X. Hu, and R. Yan Reduced Amyloid Deposition in Mice Overexpressing RTN3 Is Adversely Affected by Preformed Dystrophic Neurites J. Neurosci., July 22, 2009; 29(29): 9163 - 9173. [Abstract] [Full Text] [PDF]

				S. Kitazume, R. Oka, K. Ogawa, S. Futakawa, Y. Hagiwara, H. Takikawa, M. Kato, A. Kasahara, E. Miyoshi, N. Taniguchi, et al. Molecular insights into {beta}-galactoside {alpha}2,6-sialyltransferase secretion in vivo Glycobiology, May 1, 2009; 19(5): 479 - 487. [Abstract] [Full Text] [PDF]

				R. A. Karlnoski, A. Rosenthal, D. Kobayashi, J. Pons, J. Alamed, M. Mercer, Q. Li, M. N. Gordon, P. E. Gottschall, and D. Morgan Suppression of Amyloid Deposition Leads to Long-Term Reductions in Alzheimer's Pathologies in Tg2576 Mice J. Neurosci., April 15, 2009; 29(15): 4964 - 4971. [Abstract] [Full Text] [PDF]

				L. Giliberto, R. Borghi, A. Piccini, R. Mangerini, S. Sorbi, G. Cirmena, A. Garuti, B. Ghetti, F. Tagliavini, M. R. Mughal, et al. Mutant Presenilin 1 Increases the Expression and Activity of BACE1 J. Biol. Chem., April 3, 2009; 284(14): 9027 - 9038. [Abstract] [Full Text] [PDF]

				V. B. Kumar, M. Franko, W. A. Banks, P. Kasinadhuni, S. A. Farr, K. Vyas, V. Choudhuri, and J. E. Morley Increase in Presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing J. Exp. Biol., February 15, 2009; 212(4): 494 - 498. [Abstract] [Full Text] [PDF]

				K. S. Vetrivel, X. Meckler, Y. Chen, P. D. Nguyen, N. G. Seidah, R. Vassar, P. C. Wong, M. Fukata, M. Z. Kounnas, and G. Thinakaran Alzheimer Disease A{beta} Production in the Absence of S-Palmitoylation-dependent Targeting of BACE1 to Lipid Rafts J. Biol. Chem., February 6, 2009; 284(6): 3793 - 3803. [Abstract] [Full Text] [PDF]

				M. H. Ko and L. Puglielli Two Endoplasmic Reticulum (ER)/ER Golgi Intermediate Compartment-based Lysine Acetyltransferases Post-translationally Regulate BACE1 Levels J. Biol. Chem., January 23, 2009; 284(4): 2482 - 2492. [Abstract] [Full Text] [PDF]

				Y. Saito, Y. Sano, R. Vassar, S. Gandy, T. Nakaya, T. Yamamoto, and T. Suzuki X11 Proteins Regulate the Translocation of Amyloid {beta}-Protein Precursor (APP) into Detergent-resistant Membrane and Suppress the Amyloidogenic Cleavage of APP by {beta}-Site-cleaving Enzyme in Brain J. Biol. Chem., December 19, 2008; 283(51): 35763 - 35771. [Abstract] [Full Text] [PDF]

				S. L. Cole and R. Vassar The Role of Amyloid Precursor Protein Processing by BACE1, the {beta}-Secretase, in Alzheimer Disease Pathophysiology J. Biol. Chem., October 31, 2008; 283(44): 29621 - 29625. [Abstract] [Full Text] [PDF]

				H. Wang, L. Song, F. Laird, P. C. Wong, and H.-K. Lee BACE1 Knock-Outs Display Deficits in Activity-Dependent Potentiation of Synaptic Transmission at Mossy Fiber to CA3 Synapses in the Hippocampus J. Neurosci., August 27, 2008; 28(35): 8677 - 8681. [Abstract] [Full Text] [PDF]

				S. S. Hebert, K. Horre, L. Nicolai, A. S. Papadopoulou, W. Mandemakers, A. N. Silahtaroglu, S. Kauppinen, A. Delacourte, and B. De Strooper Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/{beta}-secretase expression PNAS, April 29, 2008; 105(17): 6415 - 6420. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help